Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2026-04-14 @ 1:55 AM
Study NCT ID:
NCT01672450
Status:
COMPLETED
Last Update Posted:
2015-07-08
First Post:
2012-08-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
Sponsor:
University of Utah
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCI56809
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None